Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. Sadoff J, Le Gars M, Shukarev G, Heerwegh D, et al. N Engl J Med 2021 Jan 13. doi: 10.1056/NEJMoa2034201.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sadoff J, Le Gars M, Shukarev G, Heerwegh D, et al. Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine. N Engl J Med 2021 Jan 13. doi: 10.1056/NEJMoa2034201.
PMID: 33440088